Suppression of FGF signaling: a putative mechanism for the chemopreventive effects of acyclic retinoid in hepatocellular carcinoma.
Wang
Lihua
L
Levin
Marc S
MS
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000503:physiopathology / Q000517:prevention & control*; D018890:Chemoprevention; D005346:Fibroblast Growth Factors / Q000502:physiology*; D006801:Humans; D008113:Liver Neoplasms / Q000503:physiopathology / Q000517:prevention & control*; D015398:Signal Transduction; D014212:Tretinoin / Q000031:analogs & derivatives* / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D014212:Tretinoin; D005346:Fibroblast Growth Factors; C034534:3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid